Collectively, our results demonstrate that miR-145 targets MMP3, as well as Oct4, Lin28, Nanog, Sox2 and ZEB1 which are upregulated by linc-DYNC2H1-4 in pancreatic cancer cells. This evidence concerns the gene SOX2 and pancreatic neoplasm.